Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
AFS, ahead, concomitant, criteria, endpoint, HTM, ideal, indefinitely, intrathoracic, joint, mutual, readout, release, suspended, track, trastuzumab, week
Removed:
marketable, representing, transducer, Treasury
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view